Difference between revisions of "Part:BBa K4601001"

 
Line 3: Line 3:
 
<partinfo>BBa_K4601001 short</partinfo>
 
<partinfo>BBa_K4601001 short</partinfo>
  
to do
+
This part is the 'E. coli' codon optimized version of ChrimsonR channelrhodopsin.
  
<!-- Add more about the biology of this part here
 
 
===Usage and Biology===
 
===Usage and Biology===
 +
ChrimsonR is a channelrhodopsin derived from the CR Chrimson of 'Chlamydomonas noctigama' that is naturally red-shifted [1]. Compared to the Chrimson, ChrimsonR contains one point mutation K176R that does not modify the absorption properties, but increases the photocurrent generated upon light irradiation. ChrimsonR is a Na+ inward pump that is also capable of transporting H<sup>+</sup>, K<sup>+</sup> and Ca<sup>2+</sup>. It is one of the few microbial opsins in clinical trials for gene therapy for patients with documented diagnosis of non-syndromic Retinitis Pigmentosa [2].
 +
 +
===References===
 +
[1] Klapoetke NC, Murata Y, Kim SS, Pulver SR, Birdsey-Benson A, Cho YK, Morimoto TK, Chuong AS, Carpenter EJ, Tian Z, Wang J, Xie Y, Yan Z, Zhang Y, Chow BY, Surek B, Melkonian M, Jayaraman V, Constantine-Paton M, Wong GK-S, Boyden ES. Independent optical excitation of distinct neural populations. Nature Methods (2014) 11: 338–346.
 +
 +
[2] GenSight Biologics. A Phase 1/2a, Open-label, non-randomized, dose-eEscalation study to evaluate the safety and tolerability of GS030 in subjects with Retinitis Pigmentosa. clinicaltrials.gov (2022).
  
 
<!-- -->
 
<!-- -->

Revision as of 14:28, 11 October 2023


ChrimsonR

This part is the 'E. coli' codon optimized version of ChrimsonR channelrhodopsin.

Usage and Biology

ChrimsonR is a channelrhodopsin derived from the CR Chrimson of 'Chlamydomonas noctigama' that is naturally red-shifted [1]. Compared to the Chrimson, ChrimsonR contains one point mutation K176R that does not modify the absorption properties, but increases the photocurrent generated upon light irradiation. ChrimsonR is a Na+ inward pump that is also capable of transporting H+, K+ and Ca2+. It is one of the few microbial opsins in clinical trials for gene therapy for patients with documented diagnosis of non-syndromic Retinitis Pigmentosa [2].

References

[1] Klapoetke NC, Murata Y, Kim SS, Pulver SR, Birdsey-Benson A, Cho YK, Morimoto TK, Chuong AS, Carpenter EJ, Tian Z, Wang J, Xie Y, Yan Z, Zhang Y, Chow BY, Surek B, Melkonian M, Jayaraman V, Constantine-Paton M, Wong GK-S, Boyden ES. Independent optical excitation of distinct neural populations. Nature Methods (2014) 11: 338–346.

[2] GenSight Biologics. A Phase 1/2a, Open-label, non-randomized, dose-eEscalation study to evaluate the safety and tolerability of GS030 in subjects with Retinitis Pigmentosa. clinicaltrials.gov (2022).

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]